Metabolic consequences of intermittent hypoxia include insulin resistance and obesity in humans (103, 104), resulting from the stabilization of the hypoxia-inducible transcription factor 1-α (HIF1-α), and from increasing sympathetic neural activity that is crucial for the regulation of glucose and fat metabolism (104). The gene discussed is HIF1A; the disease is Obesity.